How to Choose a Comparator Drug Sourcing Partner for Your Clinical Trial

What comparator drug sourcing involves and why it sits on the critical path

Comparator drugs are needed in almost every clinical study, yet they are increasingly expensive and hard to find. Choosing the right comparator drug sourcing partner is one of the most important supply decisions a sponsor makes, because a delay or shortage on the critical path can stall an entire trial. A strong partner takes a scientific approach, reading the protocol first and then building a strategy that keeps every site supplied on time and at a competitive price.

Clinical Services International (CSI) is a global leader in the clinical trial supply industry, with a team that has over 300 years of combined scientific expertise. CSI has supplied medicines to more than 1,200 clinical trials across phases 1 to 3, the kind of track record sponsors should look for when comparing partners.

The six drivers of effective comparator sourcing

A reliable partner should be able to explain how it manages all the factors that decide whether a comparator arrives on time. CSI frames this as six drivers: protocol interpretation, product access, supply continuity, cost control, speed, and supporting documents. Use these as your own evaluation checklist. Ask how a prospective partner interprets your protocol, how broad its product access is, and how it protects supply continuity when a product becomes scarce. The full range of CSI clinical trial supply services is built around these drivers.

Sourcing strategy: country-specific, global or hybrid

Every study is different, so a partner should offer more than one route to supply. CSI delivers bespoke sourcing solutions that can be country-specific, global or hybrid, drawing on a global network of qualified suppliers, manufacturers and wholesalers. A wide supplier base matters because it minimizes risk and makes it possible to source specific batches when a protocol calls for them. When you compare partners, look for one that works directly with manufacturers and authorized distributors so authenticity and traceability are never in question.

Handling complexity: comedications, combination therapies and biologics

Modern trials rarely involve a single product. The standard of care for many indications, especially in oncology, is now a combination of drugs, and comedications add suppliers, logistics and timing risk. Many comparators are also biologic medicines, which are harder to produce and distribute. A capable partner can advise on the optimal strategy for every comedication and combination therapy a protocol requires, factoring in origin of supply, price, logistics and shipment timing. CSI applies its comparator sourcing expertise to exactly these situations.

When a trial needs rescuing: supply continuity and risk management

Ask how a partner responds when a study is already in trouble. CSI supports rescue studies where procurement, sourcing, compliance, quality or timelines have gone wrong, and has sourced rescue medications such as infliximab, pembrolizumab, salbutamol, ruxolitinib, and mycophenolate mofetil for global studies, where an original partner has let them down. A partner that plans for fast or slow recruitment, expiring batches, drug shortages, and price fluctuations before they happen is far more valuable than one that only reacts after a problem appears.

Documentation and quality you should expect

Comparator sourcing is only as good as the documentation behind it. A partner should deliver products certified, with full quality and regulatory support, including Certificates of Analysis, Batch Release Certificates and Statements of Authenticity where required. Every investigational medicinal product must be certified by a Qualified Person before release, so ensure your partner has the capacity to do this n house. Dependable storage and distribution with full traceability from pickup to delivery completes the picture.

How to get started

The right comparator sourcing partner reduces complexity, protects your timeline, and controls cost from protocol analysis through final delivery. To discuss your study’s sourcing requirements with CSI’s scientific team, contact CSI to start the conversation.

Key Takeaways and FAQ

In short, the right comparator drug sourcing partner protects your timeline, budget and data from protocol analysis through final delivery. Evaluate partners on the six sourcing drivers, their strategy options, and how they handle complexity and supply risk. The questions below cover the essentials.

What is comparator drug sourcing?

Comparator drug sourcing is the procurement of the existing medicines a clinical trial tests against, including branded products, generics, and biologics, along with the documentation that proves their authenticity. Comparators sit on the critical path of almost every study, so timely and compliant sourcing is essential.

How do I choose a comparator sourcing partner?

Evaluate partners against the six drivers of effective sourcing: protocol interpretation, product access, supply continuity, cost control, speed, and supporting documents. Look for direct relationships with manufacturers and authorized distributors, bespoke country-specific, global, or hybrid strategies, and proven experience with complex and rescue studies.

What documentation should a comparator sourcing partner provide?

Products should be delivered certified, with Certificates of Analysis, Batch Release Certificates, and Statements of Authenticity where required, and every investigational medicinal product should be certified by a Qualified Person before release.